New Blood Thinner More Effective Than Warfarin

by Kathy Jones on  June 23, 2011 at 8:53 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

A new blood thinner developed by Bristol-Myers Squibb and Pfizer Inc was found to be more effective than warfarin in the Phase III trials conducted by the companies.
 New Blood Thinner More Effective Than Warfarin
New Blood Thinner More Effective Than Warfarin

The Phase II trials for the drug, known as Apixaban, was conducted with the primary aim of showing itself to be non-inferior to warfarin but researchers said that the drug was better and safer than warfarin in preventing strokes in patients with dangerously irregular heart rhythms.

The drug is expected to compete with Boehringer Ingelheim's Pradaxa and another drug, Xarelto, which has been jointly developed by Bayer and Johnson & Johnson.

Shares of Bristol-Myers rose by 7.3 percent to $29.78 while Pfizer shares also increased by 3.9 percent to $21.06 at the New York Stock Exchange.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Thalassemia Congenital Heart Disease Anticoagulants Deep Vein Thrombosis Pulmonary Embolism Hemophilia Blood in Stools - Symptom Evaluation Bombay Blood Group Common Side Effects of Anticoagulants / Blood Thinners 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive